| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f6e33603375c486b0ab3505830af9e8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2602-28 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C67-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P7-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C67-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C67-48 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P7-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P7-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-06 |
| filingDate |
2001-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_090e161045f068eb9a7308a87b2f2856
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f47ee7d55591ed9c4262377ea8fa8765
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_623eba18d2f3f24dd057221603e9a228
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7761f7229965bf954ae4d6f6ee238af8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34730982a987e97249ff51ebdcac99d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_718c33149a3f5ca5d4324230bb8850b4 |
| publicationDate |
2003-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2425883-A1 |
| titleOfInvention |
Method of purifying plavastatin |
| abstract |
A method of isolating or purifying plavastatin or its pharmacologically acceptable salt characterized by involving, in the process of isolating or purifying plavastatin or its pharmacologically acceptable salt, the step of extracting plavastatin by using an organic solvent represented by the formula CH3CO2R (wherein R represents alkyl having 3 or more carbon atoms) or the step of decomposing impurities by using an inorganic acid/an inorganic base; and compositions containing plavastatin sodium thus obtained. |
| priorityDate |
2000-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |